Hope, William

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 4,917

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityOcular Infections and Treatments

Cited by 1,217

Individualised antibiotic dosing for patients who are critically ill: Challenges and potential solutions.

Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases

Antibiotics Pharmacokinetics and EfficacyAntibiotic Use and Resistance

Cited by 1,046

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Maertens, J. A., Raad, I. I., Marr, K. A., Patterson, T. F., Kontoyiannis, D. P., Cornely, O. A., Bow, E. J., Rahav, G., Neofytos, D., Aoun, M., et al. (2016) · The Lancet

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 1,001

Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

Stone, N. R. H., Bicanic, T., Salim, R., & Hope, W. (2016) · Drugs

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 537

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. (2012) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 451

Tissue Penetration of Antifungal Agents

Felton, T., Troke, P. F., & Hope, W. W. (2014) · Clinical Microbiology Reviews

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 426

ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

Cuenca-Estrella, M., Verweij, P. E., Arendrup, M. C., Arikan-Akdagli, S., Bille, J., Donnelly, J. P., Jensen, H. E., Lass-Flörl, C., Richardson, M. D., Akova, M., et al. (2012) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 386

ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

Hope, W. W., Castagnola, E., Groll, A. H., Roilides, E., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Cornely, O. A., et al. (2012) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 360

ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Ullmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityNeutropenia and Cancer Infections

Cited by 334

Therapy for fungal diseases: opportunities and priorities

Denning, D. W., & Hope, W. W. (2010) · Trends in Microbiology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 314

F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase

Oliver, J. D., Sibley, G. E. M., Beckmann, N., Dobb, K. S., Slater, M. J., McEntee, L., du Pré, S., Livermore, J., Bromley, M. J., Wiederhold, N. P., et al. (2016) · Proceedings of the National Academy of Sciences

Antifungal resistance and susceptibilityBiochemical and Molecular Research

Cited by 289

ChatGPT and antimicrobial advice: the end of the consulting infection doctor?

Howard, A., Hope, W., & Gerada, A. (2023) · The Lancet Infectious Diseases

Artificial Intelligence in Healthcare and EducationAntibiotic Use and Resistance

Cited by 202

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis

Stone, N. R. H., Rhodes, J., Fisher, M. C., Mfinanga, S., Kivuyo, S., Rugemalila, J., Segal, E. S., Needleman, L., Molloy, S. F., Kwon-Chung, J., et al. (2019) · Journal of Clinical Investigation

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 167

Molecular Mechanisms of Primary Resistance to Flucytosine in Candida albicans

Hope, W. W., Tabernero, L., Denning, D. W., & Anderson, M. J. (2004) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 160

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. W. (2013) · Drug Resistance Updates

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 129

Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations

Arendrup, M. C., Perlin, D. S., Jensen, R. H., Howard, S. J., Goodwin, J., & Hope, W. (2012) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 117

Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial

Jarvis, J. N., Leeme, T. B., Molefi, M., Chofle, A. A., Bidwell, G., Tsholo, K., Tlhako, N., Mawoko, N., Patel, R. K. K., Tenforde, M. W., et al. (2019) · Clinical Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 86

Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance

Hope, W., Stone, N. R. H., Johnson, A., McEntee, L., Farrington, N., Santoro-Castelazo, A., Liu, X., Lucaci, A., Hughes, M., Oliver, J. D., et al. (2019) · mBio

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 70

Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections

Livermore, J., & Hope, W. (2012) · Expert Opinion on Drug Metabolism & Toxicology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 62

EUCAST technical note on Amphotericin B

Lass-Flörl, C., Arendrup, M. C., Rodriguez-Tudela, J.-L., Cuenca-Estrella, M., Donnelly, P., & Hope, W. (2011) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 49

Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts

Howard, S. J., Livermore, J., Sharp, A., Goodwin, J., Gregson, L., Alastruey-Izquierdo, A., Perlin, D. S., Warn, P. A., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityAntibiotics Pharmacokinetics and Efficacy

Cited by 48

EUCAST Technical Note on Candida and micafungin, anidulafungin and fluconazole

Cavling Arendrup, M., Cuenca‐Estrella, M., Lass‐Flörl, C., Hope, W. W., & The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) (2014) · Mycoses

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 43

EUCAST technical note on posaconazole

Arendrup, M. C., Cuenca-Estrella, M., Donnelly, J. P., Hope, W., Lass-Flörl, C., & Rodriguez-Tudela, J.-L. (2011) · Clinical Microbiology and Infection

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 34